Related Experiment Video
Updated: May 22, 2026
11:54
Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues
Published on: October 20, 2019
Preterm gestation along with partial hydatidiform mole and alive foetus.
1Department of Obstetrics and Gynecology, Dhulikhel Hospital-Kathmandu University Hospital, Nepal. drsuman537@yahoo.com
Kathmandu University Medical Journal (KUMJ)
|May 22, 2012
Summary
This case study highlights the successful management of a rare partial molar pregnancy with a viable fetus during preterm labor. It addresses the complexities of managing molar changes alongside a living fetus.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
- Maternal-Fetal Medicine
Background:
- Gestational trophoblastic disease (GTD) comprises a spectrum of placental lesions.
- Managing molar pregnancy with a coexisting viable fetus presents significant clinical challenges.
Observation:
- A case of partial molar placenta with a viable fetus in the second stage of preterm labor was encountered.
- This scenario poses diagnostic and management difficulties due to competing interests of fetal well-being and placental pathology.
Findings:
- The case demonstrates successful management despite the complex clinical situation.
- Effective intervention strategies were employed to navigate the challenges of molar changes and preterm labor.
Implications:
- This successful management offers a potential pathway for similar complex obstetric cases.
- Highlights the importance of individualized management protocols in rare obstetric complications.
- Contributes to the understanding of managing molar pregnancy with a viable fetus.
Related Concept Videos
01:33Cleavage and Blastulation
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...